Microbix Biosystems (TSE:MBX) Stock Price Passes Above 50 Day Moving Average – Should You Sell?

Shares of Microbix Biosystems Inc. (TSE:MBX) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.44 and traded as high as C$0.55. Microbix Biosystems shares last traded at C$0.55, with a volume of 414,873 shares.

Microbix Biosystems Stock Performance

The company has a debt-to-equity ratio of 22.61, a quick ratio of 5.57 and a current ratio of 7.15. The business’s 50 day moving average price is C$0.44 and its 200-day moving average price is C$0.37. The company has a market cap of C$64.54 million, a price-to-earnings ratio of 18.67 and a beta of 0.34.

Insiders Place Their Bets

In other Microbix Biosystems news, Director Bo Hollas sold 150,000 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of C$0.49, for a total transaction of C$73,500.00. Also, Director Cameron Lionel Groome sold 200,000 shares of Microbix Biosystems stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of C$0.43, for a total value of C$86,500.00. Over the last quarter, insiders have sold 400,000 shares of company stock valued at $181,000. 14.00% of the stock is currently owned by corporate insiders.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.